EP3313883
NOVEL PD-1 IMMUNE MODULATING AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.6.2016EP published:
6.12.2023EP application number:
16736667.3
EPO information:
European Patent Register
Max expiry date:
22.6.2036
Title in English:
NOVEL PD-1 IMMUNE MODULATING AGENTSLanguage of the patent:
English
Timeline
Today
23.6.2016EP application
6.12.2023EP Publication
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10065, US
Name:
Eureka Therapeutics, Inc.Address:
5858 Horton Street, Suite 370, Emeryville, CA 94608, US
Inventor
Name:
BRENTJENS, Renier J.Address:
Short Hills, New Jersey 07078, US
Name:
JACKSON, Hollie JaineAddress:
Middle Park, VIC 3206, AU
Name:
LIU, ChengAddress:
Emeryville, California 94608, US
Priority
Number:
201562183297 PDate:
23.6.2015Country:
US
Number:
201562266398 PDate:
11.12.2015Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61K 35/17, A61K 39/00, A61K 38/00, A61K 48/00, C07K 14/705, C07K 14/725, A61P 35/00